LINC02477 |
|
long intergenic non-protein coding RNA 2477
|
|
|
1.000 |
|
SLC35F4 |
A4IF30
|
solute carrier family 35 member F4
|
|
8.6E-03 |
0.931 |
0.038 |
DISC1FP1 |
|
DISC1 fusion partner 1
|
|
|
0.931 |
0.038 |
C6orf15 |
Q6UXA7
|
chromosome 6 open reading frame 15
|
|
1.1E-02 |
0.931 |
0.038 |
SNORA38 |
|
small nucleolar RNA, H/ACA box 38
|
|
|
0.890 |
0.154 |
NBPF13P |
|
NBPF member 13, pseudogene
|
|
|
0.890 |
0.038 |
ABHD16A |
O95870
|
abhydrolase domain containing 16A
|
Enzyme
|
0.47 |
0.861 |
0.269 |
ATF6B |
Q99941
|
activating transcription factor 6 beta
|
|
3.1E-07 |
0.839 |
0.192 |
TRIM10 |
Q9UDY6
|
tripartite motif containing 10
|
|
3.7E-09 |
0.821 |
0.269 |
SNHG32 |
|
small nucleolar RNA host gene 32
|
|
2.4E-02 |
0.805 |
0.308 |
USP8P1 |
|
USP8 pseudogene 1
|
|
|
0.805 |
0.269 |
HCG27 |
|
HLA complex group 27
|
|
2.3E-02 |
0.805 |
0.346 |
GNL1 |
P36915
|
G protein nucleolar 1 (putative)
|
|
1.00 |
0.805 |
0.423 |
LST1 |
O00453
|
leukocyte specific transcript 1
|
|
1.1E-03 |
0.792 |
0.308 |
ATP6V1G2-DDX39B |
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
|
0.769 |
0.423 |
HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
PSORS1C3 |
|
psoriasis susceptibility 1 candidate 3
|
|
|
0.769 |
0.269 |
RNF39 |
Q9H2S5
|
ring finger protein 39
|
|
2.0E-05 |
0.760 |
0.538 |
NBEA |
Q8NFP9
|
neurobeachin
|
|
1.00 |
0.760 |
0.538 |
GPSM3 |
Q9Y4H4
|
G protein signaling modulator 3
|
|
0.29 |
0.751 |
0.423 |
LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
MUC21 |
Q5SSG8
|
mucin 21, cell surface associated
|
|
8.0E-02 |
0.743 |
0.346 |
HCG22 |
E2RYF7
|
HLA complex group 22 (gene/pseudogene)
|
|
|
0.736 |
0.423 |
FKBPL |
Q9UIM3
|
FKBP prolyl isomerase like
|
Enzyme
|
8.0E-11 |
0.736 |
0.346 |
LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |